Uneek Mehra

Companies

• BridgeBio Oncology Therapeutics, Inc.Chief financial officer Aug 18, 2025 to now¹
• 4D Molecular Therapeutics, Inc.Officer Sep 26, 2023 to Mar 10, 2025²
• Myovant Sciences Ltd.Principal Financial Officer Sep 9, 2021 to Mar 10, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• BOBridgeBio Oncology Therapeutics, Inc. BBOT22,806 shares⁴$64.0K at $2.81Apr 1, 2026
• MSMyovant Sciences Ltd.0 shares⁵Mar 10, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 1, 2026Shares withheld for tax 524 shares at $9.03 of BridgeBio Oncology Therapeutics, Inc.⁴
• Mar 10, 2026Granted 23,330 shares of BridgeBio Oncology Therapeutics, Inc.⁶
• Mar 10, 2023Returned to company 181,972 shares of Myovant Sciences Ltd.⁵
• Mar 10, 2023Returned to company 20,724 shares of Myovant Sciences Ltd.⁵
• Dec 16, 2022Sold 2,241 shares at $26.75 of Myovant Sciences Ltd.⁷
• Sep 16, 2022Sold 9,243 shares at $18.86 of Myovant Sciences Ltd.⁸
• Apr 15, 2022Granted 111,111 shares of Myovant Sciences Ltd.⁹